Prosight Management »

Phreesia shares owned by Prosight Management

Quarter-by-quarter ownership of Phreesia (PHR) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Phreesia

Tip: Access up to 7 years of quarterly data

All positions including Phreesia held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phreesia by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $17M 977k 16.92

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Phreesia

Vanguard Group
BlackRock
FMR
Capital Research and Management Company - Division 3
Greenhouse Funds L
Franklin Resources
Deerfield Management Company
Nuveen
Champlain Investment Partners
State Street Corporation
Granahan Investment Management
Geode Capital Management
Millennium Management
American Century Companies
Jennifer Ranahan

View all funds holding Phreesia